Lydie Trautmann

Vaccine and Gene Therapy Institute of Florida

Affiliated withVaccine and Gene Therapy Institute of Florida

Research Area

Biography

Lydie Trautmann has not added Biography.
If you are Lydie Trautmann and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 25	2013

Other Publications

Article	Year
+1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10. The Journal of experimental medicine\| PubMed ID: 11828010	2002
Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens. European journal of immunology\| PubMed ID: 12555663	2002
Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1. Blood\| PubMed ID: 14563644	2004
Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16237109	2005
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nature medicine\| PubMed ID: 16917489	2006
The duration of exposure to HIV modulates the breadth and the magnitude of HIV-specific memory CD4+ T cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 17202340	2007
[Inhibition of the PD-1 pathway restores the effector function of HIV-specific T cells]. Médecine sciences : M/S\| PubMed ID: 17212925	2007
Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection. Nature medicine\| PubMed ID: 18311149	2008
T-cell exhaustion in HIV infection. Current HIV/AIDS reports\| PubMed ID: 18417030	2008
Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells. Journal of virology\| PubMed ID: 18667516	2008
Drug resistance mutations and the cellular immune response: a valuable synergy for the development of novel immune therapies. Current opinion in HIV and AIDS\| PubMed ID: 19372876	2007
Programmed death 1: a critical regulator of T-cell function and a strong target for immunotherapies for chronic viral infections. Current opinion in HIV and AIDS\| PubMed ID: 19372890	2007
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nature medicine\| PubMed ID: 19543283	2009
Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nature medicine\| PubMed ID: 20208540	2010
New approaches to design HIV-1 T-cell vaccines. Current opinion in HIV and AIDS\| PubMed ID: 20978376	2010
Solving vaccine mysteries: a systems biology perspective. Nature immunology\| PubMed ID: 21772284	2011
Ex vivo measurement of the cytotoxic capacity of human primary antigen-specific CD8 T cells. Journal of immunological methods\| PubMed ID: 21996428	2012
Clonotype and repertoire changes drive the functional improvement of HIV-specific CD8 T cell populations under conditions of limited antigenic stimulation. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 22210916	2012
Foxo3a: an integrator of immune dysfunction during HIV infection. Cytokine & growth factor reviews\| PubMed ID: 22748238	2012
Profound metabolic, functional, and cytolytic differences characterize HIV-specific CD8 T cells in primary and chronic HIV infection. Blood\| PubMed ID: 22955926	2012
Beyond surface markers with a universal cell secretion assay. Cytometry. Part A : the journal of the International Society for Analytical Cytology\| PubMed ID: 22997009	2013